§ 12–6A-01
Statutes in effect as of October 1, 2026.
Md. Code Ann., Health Occ. § 12-6A-01 (2026)
Title 12. Pharmacists and Pharmacies
Subtitle 6A. Therapy Management Contracts
§ 12–6A-01LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Authorized prescriber” means a licensed physician, licensed podiatrist, certified midwife licensed under Title 8, Subtitle 6D of this article, or certified advanced practice nurse with prescriptive authority under § 8–508 of this article.
(c)
“Group model health maintenance organization” has the meaning stated in § 19–713.6 of the Health – General Article.
(d)
“Health maintenance organization” has the meaning stated in § 19–701(g) of the Health – General Article.
(e)
(1)
“Institutional facility” means a facility other than a nursing home whose primary purpose is to provide a physical environment for patients to obtain inpatient or emergency care.
(2)
“Institutional facility” does not include an urgent care facility that is not part of a facility.
(f)
“Prescriber–pharmacist agreement” means an agreement between an authorized prescriber and a licensed pharmacist that is disease–state specific and specifies the protocols that may be used.
(g)
“Protocol” means a course of treatment predetermined by the authorized prescriber and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention.
(h)
“Therapy management contract” means a voluntary arrangement that is:
(1)
Disease–state specific;
(2)
Agreed on by:
(i)
One licensed pharmacist and the licensed pharmacist’s designated alternate licensed pharmacists;
(ii)
One authorized prescriber and alternate designated authorized prescribers involved directly in patient care; and
(iii)
One patient receiving care from an authorized prescriber and a licensed pharmacist pursuant to a prescriber–pharmacist agreement and protocol under this subtitle; and
(3)
Related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations for the purpose of improving patient outcomes.